https://clinicaltrials.gov/ct2/show/NCT02597361
Angiotensin II Receptor Blockade in Vascular Ehlers Danlos Syndrome (ARCADE)
Study Type : Interventional (Clinical Trial)
Estimated Enrollment : 108 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment
Official Title: Angiotensin II Receptor Blockade in Vascular Ehlers Danlos Syndrome: a Double Blind, Randomized, Placebo Controlled, Multicenter Trial.
Actual Study Start Date : January 2016
Estimated Primary Completion Date : April 2020
Estimated Study Completion Date : April 2020
